Several small-molecule tyrosine kinase (TK) inhibitors directed towards RET kinase have been tested in preclinical and clinical studies and have been proven to be effective in the treatment of several neoplastic disease, including thyroid cancers [58]. Here, TKT is linked to thyroid cancer.